Publication details
HLA
-G and HLA
-E specific mRNAs connote opposite prognostic significance in renal cell carcinoma
| Basic information | |
|---|---|
| Original title: | HLA -G and HLA -E specific mRNAs connote opposite prognostic significance in renal cell carcinoma |
| Authors: | Leoš Křen, Ivo Valkovský, Jan Doležel, Ivo Čapák, Dalibor Pacík, Alexandr Poprach, Radek Lakomý, Martina Rédová, Pavel Fabian, Zdenka Křenová, Ondřej Slabý |
| Further information | |
|---|---|
| Citation: | KŘEN, Leoš, Ivo VALKOVSKÝ, Jan DOLEŽEL, Ivo ČAPÁK, Dalibor
PACÍK, Alexandr POPRACH, Radek LAKOMÝ, Martina RÉDOVÁ, Pavel
FABIAN, Zdenka KŘENOVÁ and Ondřej SLABÝ. HLA -G and HLA -E
specific mRNAs connote opposite prognostic significance in
renal cell carcinoma. Diagnostic Pathology, LONDON: BIOMED
CENTRAL LTD, 2012, vol. 7, No 1, p. 58 -64. ISSN 1746 -1596.
doi:10.1186/1746 -1596 -7 -58.Export BibTeX |
| Original language: | English |
| Field: | Oncology and hematology |
| WWW: | http://www.diagnosticpathology.org/content/pdf/1746 -1596 -7 -58.pdf |
| Type: | Article in Periodical |
| Keywords: | renal cell carcinoma; radiotherapy; chemotherapy; HLA -G; HLA -E |
Background: Renal cell carcinoma (RCC) is characterized by its resistance to radiotherapy and/or chemotherapy. On the other hand, it is an immunogenic tumor - it is able to stimulate antitumor responses. A prognostic significance of HLA-G expression by neoplastic cells in RCC is not well characterized; significance HLA-E expression in RCC is not characterized at all. Methods: In our study, we evaluated the expression of HLA-G and HLA-E specific mRNA transcripts produced by neoplastic cells in 38 cases of RCC and in 10 samples of normal kidney parenchyma. The results were statistically correlated with various clinico-pathological parameters. Results: We confirmed that HLA-G is downregulated in normal kidney tissue; if it is up-regulated in RCC, then it is connected to worse prognosis. On the other hand, HLA-E mRNA transcripts were present in both normal kidney tissue and RCC and their increasing concentrations counterintuitively carried better prognosis, more favorable pT stage and lower nuclear Fuhrmann's grade. Conclusion: Considering the fact that there is known aberrant activation of HLA-G and HLA-E expression by interferons, identification of HLA-G and HLA-E status could contribute to better selection of RCC patients who could possibly benefit from more tailored neoadjuvant biological/immunological therapy. Thus, these molecules could represent useful prognostic biomarkers in RCC, and the expression of both these molecules in RCC deserves further study. The virtual: Slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/vs/7383071387016614
Related projects:











http://www.diagnosticpathology.org/content/pdf/1746